Presentation raises questions about EBV timing. Dalia Rotstein, MD, of the University of Toronto, discussed the findings and their implications in an oral presentation at the Amer ...
Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide. With MS, the immune system mistakenly attacks the myelin sheath—a protective layer ...
Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...
A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), a chronic inflammatory disease that affects nearly 3 million people ...
BUFFALO, N.Y. — Researchers from the University at Buffalo revealed their findings on Wednesday morning from a study focusing on people living with multiple sclerosis both here in Buffalo and in ...
BOSTON — The first formal phase 1 study of mesenchymal stem cells for multiple sclerosis (MS) to be conducted in North America has shown no safety issues. "The goal was to show safety, feasibility and ...
People with multiple sclerosis (MS) may show warning signs long before classic symptoms appear — and mental health concerns could be among the first red flags, according to new research. A University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results